Alexion Gets Priority Review on Soliris
14th Nov 2006, 16:38 GMT
Biotech drug maker Alexion Pharmaceuticals said the FDA granted its proposed anemia treatment priority review.
Alexion Gets Priority Review on Soliris related news:
- Alexion's Soliris granted priority review — United Press International - Health Business
- Alexion gets fast-track FDA review for drug Soliris — bizjournals.com Health Care:Pharmaceuticals headlines
- FDA Grants Priority Review for Soliris BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — StratWire - Business of Healthcare NewsFeed
- Alexion Blood Disorder Treatment Granted Priority Review — RedOrbit News - Health
- FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — PR Newswire: All Releases
- DEP in 99: Accutherm cleanup a priority. — Environmental Health News
- MassDevelopment names priority brownfield development sites — bizjournals.com Economic View:Economic Snapshot headlines
- Indo-US nuke deal to get top priority in Lame Duck session — NewKerala World News
- More Americans rank Iraq as the top priority of the new Democratic-controlled ... — U.S. News on Yahoo! News Photos
- Alexion Pharmaceuticals Announces Proposed Public Offering of Common Stock — PR Newswire: All Releases
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress